IBERSOL,SGPS And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – IBERSOL,SGPS (IBS.LS), ELIS (ELIS.PA), NORWEGIAN AIR SHUT (NAS.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. IBERSOL,SGPS (IBS.LS)

500.5% sales growth and 35.54% return on equity

Ibersol, S.G.P.S., S.A., through its subsidiaries, operates a network of restaurants in Portugal, Spain, and Angola. The company operates restaurants under various brands, including Pizza Hut, Pasta Caffé, Pans & Company, Ribs, FresCo, SantaMaria, Kentucky Fried Chicken, Burger King, O' Kilo, Quiosques, Pizza Móvil, Miit, Taco Bell, Sol, Silva Carvalho Catering e Palace Catering, Travel, coffee counters, and other concessions contract. The company was founded in 1989 and is headquartered in Porto, Portugal. Ibersol, S.G.P.S., S.A. is a subsidiary of ATPS – SGPS, S.A.

Earnings Per Share

As for profitability, IBERSOL,SGPS has a trailing twelve months EPS of €1.98.

PE Ratio

IBERSOL,SGPS has a trailing twelve months price to earnings ratio of 3.33. Meaning, the purchaser of the share is investing €3.33 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.54%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 17, 2022, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 2.15%.

Moving Average

IBERSOL,SGPS’s worth is way above its 50-day moving average of €5.94 and way higher than its 200-day moving average of €5.91.

Yearly Top and Bottom Value

IBERSOL,SGPS’s stock is valued at €6.60 at 07:20 EST, way below its 52-week low of €5.00.

Volume

Today’s last reported volume for IBERSOL,SGPS is 1 which is 99.99% below its average volume of 11126.

More news about IBERSOL,SGPS.

2. ELIS (ELIS.PA)

77.2% sales growth and 5.03% return on equity

Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.

Earnings Per Share

As for profitability, ELIS has a trailing twelve months EPS of €0.86.

PE Ratio

ELIS has a trailing twelve months price to earnings ratio of 20.49. Meaning, the purchaser of the share is investing €20.49 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.03%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 3.46B for the twelve trailing months.

Sales Growth

ELIS’s sales growth for the next quarter is 77.2%.

More news about ELIS.

3. NORWEGIAN AIR SHUT (NAS.OL)

31.3% sales growth and 26.91% return on equity

Norwegian Air Shuttle ASA, together with its subsidiaries, provides scheduled and charter airline services in Norway and internationally. As of December 31, 2021, the company operated a fleet of 70 aircraft. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, NORWEGIAN AIR SHUT has a trailing twelve months EPS of kr0.1.

PE Ratio

NORWEGIAN AIR SHUT has a trailing twelve months price to earnings ratio of 99.56. Meaning, the purchaser of the share is investing kr99.56 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.91%.

Sales Growth

NORWEGIAN AIR SHUT’s sales growth is 83.6% for the present quarter and 31.3% for the next.

Moving Average

NORWEGIAN AIR SHUT’s value is under its 50-day moving average of kr10.62 and way higher than its 200-day moving average of kr8.91.

More news about NORWEGIAN AIR SHUT.

4. RANA GRUBER (RANA.OL)

24.5% sales growth and 68.94% return on equity

Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.

Earnings Per Share

As for profitability, RANA GRUBER has a trailing twelve months EPS of kr12.68.

PE Ratio

RANA GRUBER has a trailing twelve months price to earnings ratio of 4.69. Meaning, the purchaser of the share is investing kr4.69 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.94%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 38.5%, now sitting on 1.42B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

RANA GRUBER’s EBITDA is 4.35.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 573.6% and a drop 29.5% for the next.

More news about RANA GRUBER.

5. SKUE SPAREBANK (SKUE.OL)

17% sales growth and 9.06% return on equity

Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, personal, vehicle, and small loans, as well as mortgage, bank guarantee, overdraft, and leasing services; and home and leisure, car and other vehicles, pet, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.

Earnings Per Share

As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr82.41.

PE Ratio

SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.69. Meaning, the purchaser of the share is investing kr2.69 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.06%.

More news about SKUE SPAREBANK.

6. NAVAMEDIC (NAVA.OL)

9.6% sales growth and 16.31% return on equity

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.46.

PE Ratio

NAVAMEDIC has a trailing twelve months price to earnings ratio of 81.09. Meaning, the purchaser of the share is investing kr81.09 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.

Yearly Top and Bottom Value

NAVAMEDIC’s stock is valued at kr37.30 at 07:20 EST, way under its 52-week high of kr43.60 and way above its 52-week low of kr25.00.

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.6%, now sitting on 382.14M for the twelve trailing months.

Sales Growth

NAVAMEDIC’s sales growth is 72.2% for the ongoing quarter and 9.6% for the next.

Moving Average

NAVAMEDIC’s value is below its 50-day moving average of kr37.76 and way above its 200-day moving average of kr33.78.

More news about NAVAMEDIC.

Leave a Reply

Your email address will not be published. Required fields are marked *